Department of Urology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Department of Urology, Gauhati Medical College and Hospital, Guwahati, India.
Ann Surg Oncol. 2024 May;31(5):3544-3553. doi: 10.1245/s10434-024-15051-z. Epub 2024 Feb 21.
Existing data on the histopathological correlation of testicular tumors with lymph node prognosis have been poorly explored. We aimed to investigate the relationship of the histopathological properties of testicular tumors with lymph nodes and their involvement with chemoresistance and heterogeneity of testicular tumors.
Patients with non-seminomatous germ cell tumor (NSGCT) were selected for histopathological correlation of testicular tumor with lymph nodes and its relationship with chemoresistance and heterogeneity. Histopathological and radiological parameters associated with the risk of chemoresistance and tumor progression were measured pre- and post-chemotherapy. Binomial logistic regression and Kaplan-Meier analysis were implemented to determine the predictors of progression and adverse overall patient survival. All categorical variables were analyzed using the Chi-square test, while Pearson's R coefficient determined the correlation.
Male patients who were diagnosed with NSGCT from March 2017 to December 2018 at Guwahati Medical College, Guwahati, India, were included in this study. Lymph node groups were predominantly incriminated with the EYST or EYS groups and minimally linked with the pure E and YCS groups. Furthermore, the highest number of lymph node stations was associated with pre-chemotherapy. In salvage chemotherapy in the form of VIP, we found exciting outcomes, as approximately 41% of cases responded positively, especially in the EYS group.
Our study classifies NSGCT according to the most favorable histopathological grouping and explores the tumoral response in different intrinsic and extrinsic variables. Our analysis can serve as a triumphant histopathological nomogram for a sublime management protocol to deal with the onerous histological pairing in NSGCT.
现有数据对睾丸肿瘤与淋巴结预后的组织病理学相关性研究甚少。本研究旨在探讨睾丸肿瘤的组织病理学特征与淋巴结的关系,以及它们与化疗耐药性和睾丸肿瘤异质性的关系。
选择非精原细胞瘤性生殖细胞肿瘤(NSGCT)患者,进行睾丸肿瘤与淋巴结的组织病理学相关性及其与化疗耐药性和异质性的关系研究。在化疗前后测量与化疗耐药和肿瘤进展相关的组织病理学和影像学参数。采用二项逻辑回归和 Kaplan-Meier 分析确定进展和不良总患者生存的预测因素。所有分类变量均采用卡方检验进行分析,Pearson R 系数用于确定相关性。
本研究纳入了 2017 年 3 月至 2018 年 12 月在印度古瓦哈蒂医学院诊断为 NSGCT 的男性患者。淋巴结组主要与 EYST 或 EYS 组相关,与纯 E 和 YCS 组关联较少。此外,化疗前淋巴结站数最多。在 VIP 形式的挽救性化疗中,我们发现了令人兴奋的结果,大约 41%的病例反应良好,特别是在 EYS 组。
本研究根据最有利的组织病理学分组对 NSGCT 进行分类,并探讨了不同内在和外在变量下的肿瘤反应。我们的分析可以作为一种成功的组织病理学列线图,为 NSGCT 处理繁重的组织学配对提供一个崇高的管理方案。